TWI595089B - Industrial scale process of cultivating ganoderma lucidum mycelium - Google Patents
Industrial scale process of cultivating ganoderma lucidum mycelium Download PDFInfo
- Publication number
- TWI595089B TWI595089B TW102128574A TW102128574A TWI595089B TW I595089 B TWI595089 B TW I595089B TW 102128574 A TW102128574 A TW 102128574A TW 102128574 A TW102128574 A TW 102128574A TW I595089 B TWI595089 B TW I595089B
- Authority
- TW
- Taiwan
- Prior art keywords
- culture
- ganoderma lucidum
- mycelium
- days
- liquid medium
- Prior art date
Links
- 240000008397 Ganoderma lucidum Species 0.000 title claims description 52
- 235000001637 Ganoderma lucidum Nutrition 0.000 title claims description 52
- 238000000034 method Methods 0.000 title claims description 26
- 230000008569 process Effects 0.000 title description 2
- 239000007788 liquid Substances 0.000 claims description 27
- 238000009630 liquid culture Methods 0.000 claims description 25
- OTUZGGSAOMCYNC-AEGHVTTBSA-N Ganoderic acid Me Chemical compound CC1(C)[C@H](OC(C)=O)CC[C@]2(C)C3=CC[C@]4(C)[C@@H]([C@@H](CC\C=C(/C)C(O)=O)C)C[C@H](OC(C)=O)[C@@]4(C)C3=CC[C@H]21 OTUZGGSAOMCYNC-AEGHVTTBSA-N 0.000 claims description 20
- OTUZGGSAOMCYNC-UHFFFAOYSA-N UNPD47180 Natural products CC1(C)C(OC(C)=O)CCC2(C)C3=CCC4(C)C(C(CCC=C(C)C(O)=O)C)CC(OC(C)=O)C4(C)C3=CCC21 OTUZGGSAOMCYNC-UHFFFAOYSA-N 0.000 claims description 20
- 150000003648 triterpenes Chemical class 0.000 claims description 14
- OTUZGGSAOMCYNC-CRTLAZRUSA-N (E,6R)-6-[(3S,5R,10S,13R,14R,15S,17R)-3,15-diacetyloxy-4,4,10,13,14-pentamethyl-2,3,5,6,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methylhept-2-enoic acid Chemical compound CC1(C)[C@@H](OC(C)=O)CC[C@]2(C)C3=CC[C@]4(C)[C@@H]([C@@H](CC\C=C(/C)C(O)=O)C)C[C@H](OC(C)=O)[C@@]4(C)C3=CC[C@H]21 OTUZGGSAOMCYNC-CRTLAZRUSA-N 0.000 claims description 10
- OCLVBEOPEKEKNM-CAXIOAJTSA-N Ganoderic Acid T Chemical compound CC1(C)[C@H](OC(C)=O)CC[C@]2(C)C3=CC[C@]4(C)[C@@H]([C@@H]([C@H](C\C=C(/C)C(O)=O)OC(C)=O)C)C[C@H](OC(C)=O)[C@@]4(C)C3=CC[C@H]21 OCLVBEOPEKEKNM-CAXIOAJTSA-N 0.000 claims description 10
- RXLRLJSRXDHQCH-WXUPVFRZSA-N Ganoderic acid R Natural products O([C@H]([C@@H](C)[C@@H]1[C@]2(C)[C@](C)(C=3C([C@]4(C)[C@H](C(C)(C)[C@H](OC(=O)C)CC4)CC=3)=CC2)CC1)C/C=C(\C(=O)O)/C)C(=O)C RXLRLJSRXDHQCH-WXUPVFRZSA-N 0.000 claims description 10
- RXLRLJSRXDHQCH-ASNKJFCVSA-N Ganoderic acid R Chemical compound CC1(C)[C@H](OC(C)=O)CC[C@]2(C)C3=CC[C@]4(C)[C@@H]([C@@H]([C@H](C\C=C(/C)C(O)=O)OC(C)=O)C)CC[C@@]4(C)C3=CC[C@H]21 RXLRLJSRXDHQCH-ASNKJFCVSA-N 0.000 claims description 10
- AQUHIKXTCOSRFY-GOEVOFJGSA-N Ganoderic acid S Chemical compound CC1(C)C(=O)CC[C@]2(C)C3=CC[C@]4(C)[C@@H]([C@@H](CC\C=C(\C)C(O)=O)C)CC[C@@]4(C)C3=CC[C@H]21 AQUHIKXTCOSRFY-GOEVOFJGSA-N 0.000 claims description 10
- FRRMMEJOPQSLSE-UHFFFAOYSA-N Ganoderic acid S Natural products CC1(C)C(O)CCC2(C)C3=CCC4(C)C(C(C(CC=C(C)C(O)=O)OC(C)=O)C)CCC4(C)C3=CCC21 FRRMMEJOPQSLSE-UHFFFAOYSA-N 0.000 claims description 10
- OCLVBEOPEKEKNM-UHFFFAOYSA-N ganoderic acid T Natural products CC1(C)C(OC(C)=O)CCC2(C)C3=CCC4(C)C(C(C(CC=C(C)C(O)=O)OC(C)=O)C)CC(OC(C)=O)C4(C)C3=CCC21 OCLVBEOPEKEKNM-UHFFFAOYSA-N 0.000 claims description 10
- AQUHIKXTCOSRFY-UHFFFAOYSA-N tyromycic acid Natural products CC1(C)C(=O)CCC2(C)C3=CCC4(C)C(C(CCC=C(C)C(O)=O)C)CCC4(C)C3=CCC21 AQUHIKXTCOSRFY-UHFFFAOYSA-N 0.000 claims description 10
- -1 triterpene compound Chemical class 0.000 claims description 8
- 238000009423 ventilation Methods 0.000 claims description 8
- 239000001888 Peptone Substances 0.000 claims description 6
- 108010080698 Peptones Proteins 0.000 claims description 6
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 6
- 229930006000 Sucrose Natural products 0.000 claims description 6
- 238000005286 illumination Methods 0.000 claims description 6
- 235000019319 peptone Nutrition 0.000 claims description 6
- 239000005720 sucrose Substances 0.000 claims description 6
- 239000012138 yeast extract Substances 0.000 claims description 6
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 5
- 239000002253 acid Substances 0.000 claims description 5
- 229940041514 candida albicans extract Drugs 0.000 claims description 5
- 239000008103 glucose Substances 0.000 claims description 5
- 235000013312 flour Nutrition 0.000 claims description 4
- 238000001035 drying Methods 0.000 claims description 3
- 238000003306 harvesting Methods 0.000 claims description 3
- 150000003839 salts Chemical class 0.000 claims description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 2
- 239000002609 medium Substances 0.000 claims 6
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims 1
- 239000001963 growth medium Substances 0.000 claims 1
- 238000011534 incubation Methods 0.000 description 23
- 238000005273 aeration Methods 0.000 description 9
- 241000222336 Ganoderma Species 0.000 description 7
- 238000013019 agitation Methods 0.000 description 6
- 229930182735 Ganoderic acid Natural products 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 238000000855 fermentation Methods 0.000 description 5
- 230000004151 fermentation Effects 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 238000003756 stirring Methods 0.000 description 5
- 238000011081 inoculation Methods 0.000 description 4
- 230000010355 oscillation Effects 0.000 description 4
- RDMQPKIDHAFXKA-JNORPAGFSA-N Ganoderic Acid Am1 Chemical compound C([C@@]12C)C[C@H](O)C(C)(C)[C@@H]1CC(=O)C1=C2C(=O)C[C@]2(C)[C@@H]([C@@H](CC(=O)CC(C)C(O)=O)C)CC(=O)[C@]21C RDMQPKIDHAFXKA-JNORPAGFSA-N 0.000 description 3
- 230000003321 amplification Effects 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 238000012364 cultivation method Methods 0.000 description 3
- 230000005764 inhibitory process Effects 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 238000003199 nucleic acid amplification method Methods 0.000 description 3
- YTVGSCZIHGRVAV-IYAQLQCNSA-N Ganoderic Acid D Chemical compound C([C@@]12C)CC(=O)C(C)(C)[C@@H]1C[C@H](O)C1=C2C(=O)C[C@]2(C)[C@@H]([C@@H](CC(=O)CC(C)C(O)=O)C)CC(=O)[C@]21C YTVGSCZIHGRVAV-IYAQLQCNSA-N 0.000 description 2
- IEDDICKFTXIWIP-UHFFFAOYSA-N Ganoderic acid D Natural products CC(CC(=O)CCC1CC(=O)C2(C)C3=C(C(=O)CC12C)C4(C)CCC(=O)C(C)(C)C4CC3O)C(=O)O IEDDICKFTXIWIP-UHFFFAOYSA-N 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 238000012136 culture method Methods 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- GMVPRGQOIOIIMI-UHFFFAOYSA-N (8R,11R,12R,13E,15S)-11,15-Dihydroxy-9-oxo-13-prostenoic acid Natural products CCCCCC(O)C=CC1C(O)CC(=O)C1CCCCCCC(O)=O GMVPRGQOIOIIMI-UHFFFAOYSA-N 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 206010008342 Cervix carcinoma Diseases 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- YCWGPALSXRBKTM-IGULHRHQSA-N Ganoderic Acid X Natural products C[C@H](CCC=C(C)C(=O)O)[C@H]1C[C@H](OC(=O)C)[C@@]2(C)C3=CC[C@H]4C(C)(C)[C@H](O)CC[C@]4(C)C3=CC[C@]12C YCWGPALSXRBKTM-IGULHRHQSA-N 0.000 description 1
- YCWGPALSXRBKTM-FKJOTFDOSA-N Ganoderic Acid X Chemical compound CC1(C)[C@@H](O)CC[C@]2(C)C3=CC[C@]4(C)[C@@H]([C@@H](CC\C=C(/C)C(O)=O)C)C[C@H](OC(C)=O)[C@@]4(C)C3=CC[C@H]21 YCWGPALSXRBKTM-FKJOTFDOSA-N 0.000 description 1
- YCWGPALSXRBKTM-UHFFFAOYSA-N Ganodermic acid TN Natural products CC1(C)C(O)CCC2(C)C3=CCC4(C)C(C(CCC=C(C)C(O)=O)C)CC(OC(C)=O)C4(C)C3=CCC21 YCWGPALSXRBKTM-UHFFFAOYSA-N 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 description 1
- 241000219094 Vitaceae Species 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 229960000711 alprostadil Drugs 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000003276 anti-hypertensive effect Effects 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 238000010923 batch production Methods 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 230000036755 cellular response Effects 0.000 description 1
- 201000010881 cervical cancer Diseases 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 229930188845 ganoderic aldehyde Natural products 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 235000021021 grapes Nutrition 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 206010073071 hepatocellular carcinoma Diseases 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 201000005202 lung cancer Diseases 0.000 description 1
- 208000020816 lung neoplasm Diseases 0.000 description 1
- 230000007721 medicinal effect Effects 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 229940068065 phytosterols Drugs 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- GMVPRGQOIOIIMI-DWKJAMRDSA-N prostaglandin E1 Chemical compound CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(O)=O GMVPRGQOIOIIMI-DWKJAMRDSA-N 0.000 description 1
- XEYBRNLFEZDVAW-UHFFFAOYSA-N prostaglandin E2 Natural products CCCCCC(O)C=CC1C(O)CC(=O)C1CC=CCCCC(O)=O XEYBRNLFEZDVAW-UHFFFAOYSA-N 0.000 description 1
- 238000013341 scale-up Methods 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- DSNBHJFQCNUKMA-SCKDECHMSA-N thromboxane A2 Chemical compound OC(=O)CCC\C=C/C[C@@H]1[C@@H](/C=C/[C@@H](O)CCCCC)O[C@@H]2O[C@H]1C2 DSNBHJFQCNUKMA-SCKDECHMSA-N 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
Landscapes
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Mushroom Cultivation (AREA)
Description
本揭示內容是有關於一種工業級的靈芝培養方法,特別是用以培養靈芝菌絲體,而非靈芝子實體的工業級培養方法。 The present disclosure relates to an industrial grade ganoderma lucidum culture method, particularly an industrial grade culture method for cultivating Ganoderma lucidum mycelium rather than Ganoderma lucidum fruiting bodies.
長久以來,在東南亞地區,食用性真菌都被當作營養補充品或健康食品來使用,其中又以靈芝(Ganoderma Iucidum)為大宗,且因其具有醫療效果也被當作藥材使用超過千年之久。自靈芝中分離出來的活性成分大致包括靈芝三萜類(triterpenoids)、多醣體(polysaccharides)、核苷(nucleic acids)、多肽類(polypeptides)、和植物固醇類(phytosterols)等等。在這些活性成分中,又以靈芝三萜類最重要,因其具有藥學活性,包括抑制膽固醇合成、抗癌、抗高血壓等等。靈芝三萜類包含各式靈芝酸(ganoderic acids,GAs)、赤靈酸(ganodermic acids,GMAs)、靈芝醇(ganoderic alcohol)、靈芝酮(ganoderic ketone)、靈芝醛(ganoderic aldehyde)等化合物。在靈芝酸的相關研究中發現,靈芝酸具有可殺死癌細胞的細胞毒性和抑制其擴增的效果。舉例來說,已知靈芝酸D(ganoderic acid D,GAD)可防止人類子宮頸 癌細胞(即,Hela細胞)增生(Yue et al.,Mol Cell Proteomics(2008)7:949-961);靈芝酸A和H(ganoderic acids A and H;簡稱GAA及GAH)可抑制乳癌細胞生長或防止其侵犯其他組織(Jiang et al.,Int J Mol Med(2008)21:577-584);靈芝酸X(ganoderic acid X,GAX)可抑制拓樸酶活性並能誘使肝癌細胞進入細胞凋亡程序(Li et al.,Life Sci.(2005)77,252-265);靈芝酸M除了可有效地抑制癌細胞生長外,還可抑制肺癌細胞的遷移(Wang et al.,Int Immunopharmacol(2007)7:864-870),GMAS則已知可誘發血小板聚集(Wang et al.,Biochim.Biophys.Acta.(1989)986,151-160)、抑制血小板功能(Wang et al.,Biochem.J.(1991)277(Pt 1),189-197)和抑制由血栓素A2(Su et al.,Biochem.Pharmacol.(1999)58,587-595;Su et al.,Biochim.Biophys.Acta.(1999b)1437,223-234)或前列腺素E1(Su et al.,Thromb.Res.(1999c)99,135-145)在血小板中所誘發的細胞反應。 For a long time, in Southeast Asia, edible fungi have been used as nutritional supplements or health foods, among which Ganoderma Iucidum is a large one, and because of its medical effects, it has been used as a medicine for more than a thousand years. . The active ingredients isolated from Ganoderma lucidum generally include triterpenoids, polysaccharides, nucleic acids, polypeptides, and phytosterols. Among these active ingredients, Ganoderma lucidum triterpenoids are most important because of their pharmaceutically active activities, including inhibition of cholesterol synthesis, anticancer, antihypertensive and the like. Ganoderma lucidum triterpenoids include various compounds such as ganoderic acids (GAs), ganodermic acids (GMAs), ganoderic alcohols, ganoderic ketones, and ganoderic aldehydes. In a related study of ganoderic acid, it was found that ganoderic acid has the effect of killing cytotoxicity of cancer cells and inhibiting the amplification thereof. For example, ganoderic acid D (GAD) is known to prevent proliferation of human cervical cancer cells (ie, Hela cells) (Yue et al., Mol Cell Proteomics (2008) 7: 949-961); Acids A and H (GAA and GAH) can inhibit the growth of breast cancer cells or prevent them from invading other tissues (Jiang et al., Int J Mol Med (2008) 21: 577-584); Ganoderma acid X (ganoderic acid X, GAX) inhibits topographic enzyme activity and induces hepatoma cells to enter the apoptotic program (Li et al., Life Sci. (2005) 77, 252-265); Ganoderma lucidum M can effectively inhibit cancer In addition to cell growth, it also inhibits the migration of lung cancer cells (Wang et al., Int Immunopharmacol (2007) 7: 864-870), which is known to induce platelet aggregation (Wang et al., Biochim. Biophys. Acta. 1989) 986, 151-160), inhibition of platelet function (Wang et al., Biochem. J. (1991) 277 (Pt 1), 189-197) and inhibition by thromboxane A2 (Su et al., Biochem. Pharmacol. 1999) 58, 587-595; Su et al., Biochim. Biophys. Acta. (1999b) 1437, 223-234) or prostaglandin E1 (Su et al., Thromb. Res. (1999c) 99, 135-145) in platelets Induced cellular response
過去,靈芝僅能在自然環境中生長或僅出現 在偏遠高山的老樹上。但是,隨著靈芝培育技術不斷被改進,現在已可在人工環境下培育出靈芝,但多半使用固態基質;例如,日本公開專利第57014816號揭示一種透過將赤芝孢子種植在木材中而來培育赤芝的方法,但此方法的缺點是產率太低,因播種孢子本身就需要花費許多人力,且培育期太長,需等到120至150天才能採收,此外,所長成的靈芝及其所含活性化合物(三萜類化合物)之種類與含量都與天然靈芝相去甚遠。 In the past, Ganoderma lucidum can only grow in the natural environment or only appear On the old trees in the remote mountains. However, as the cultivation technology of Ganoderma lucidum has been continuously improved, Ganoderma lucidum can now be cultivated in an artificial environment, but most of the solid substrate is used; for example, Japanese Laid-Open Patent No. 57014816 discloses a cultivation of Ganoderma lucidum by planting the spores of Ganoderma lucidum in wood. The method, but the disadvantage of this method is that the yield is too low, because it takes a lot of manpower to sow the spore itself, and the incubation period is too long, it takes 120 to 150 days to harvest, in addition, the grown Ganoderma lucidum and its contains The type and content of active compounds (triterpenoids) are far removed from natural ganoderma lucidum.
基於此,相關領域亟需一種改良的靈芝培育 方法,其可在極短的時間內產生可供製造藥物用的靈芝 活性化合物。 Based on this, there is an urgent need for an improved cultivation of Ganoderma lucidum. a method for producing a ganoderma for manufacturing a drug in a very short period of time Active compound.
因此,本揭示內容目的是提供一種用以培育靈芝,特別是用以培育靈芝菌絲體,而非子實體,的工業級培育方法。依據本揭示內容,每隔30天可自約300公升的液態培養物中收成高達約15公斤的乾燥靈芝菌絲體,且所收成的乾燥靈芝菌絲體中富含高量的三萜化合物,其至少包含靈芝酸S(ganoderic acid S,GAS)、靈芝酸T(ganoderic acid T,GAT)、靈芝酸Me(ganoderic acid Me,GAMe)、靈芝酸R(ganoderic acid R,GAR)、及赤靈酸S(ganodermic acid S,GMAS)。依據一較佳實施方式,由所述方法培育而成的靈芝菌絲體,每公克乾燥菌絲體含有約28-33毫克的三萜化合物。 Accordingly, it is an object of the present disclosure to provide an industrial grade cultivation method for cultivating Ganoderma lucidum, particularly for cultivating Ganoderma lucidum mycelium, rather than fruiting bodies. According to the present disclosure, up to about 15 kg of dried Ganoderma lucidum mycelium can be harvested from about 300 liters of liquid culture every 30 days, and the harvested dried Ganoderma lucidum mycelium is rich in high amounts of triterpenoids. It comprises at least ganoderic acid S (GAS), ganoderic acid T (GAT), ganoderic acid Me (GAMe), ganoderic acid R (GAR), and red spirit Acid S (ganodermic acid S, GMAS). According to a preferred embodiment, the Ganoderma lucidum mycelium cultivated by the method contains about 28-33 mg of a triterpenoid compound per gram of dry mycelium.
所揭示工業級培育靈芝菌絲體的方法包含以下步驟:(a)將靈芝菌絲體接種在不超過1公升的液態培養基中並培育約5-15天;(b)將步驟(a)所收成的液態培育物接種在至少30公升的液態培養基中並培育約2-5天;(c)將步驟(b)所收成的液態培育物接種在至少300公升的液態培養基中並培育約2-5天;以及(d)將步驟(c)所收成的液態培育物移轉到複數個培養盤中,使每一培養盤中每毫升液態培養基分別具有約1.5-2.5平方公分的表面積,並且在介於約200-2,000照度下培育約10-20天。 The disclosed industrial grade method for cultivating Ganoderma lucidum mycelium comprises the steps of: (a) inoculating the ganoderma mycelium in a liquid medium of no more than 1 liter and incubating for about 5-15 days; (b) using step (a) The harvested liquid culture is inoculated in at least 30 liters of liquid medium and incubated for about 2-5 days; (c) inoculation of the liquid culture harvested in step (b) in at least 300 liters of liquid medium and cultivating about 2 5 days; and (d) transferring the liquid culture collected in step (c) to a plurality of culture trays, each having a surface area of about 1.5 to 2.5 square centimeters per ml of liquid medium, and Incubate for about 10-20 days at about 200-2,000 illuminance.
依據一較佳實施方式,所揭示方法的每一步 驟均是在介於約20-35℃的溫度、約50-100%的相對濕度、以及約5-200LPM(公升/分鐘)的通氣量下實施。 According to a preferred embodiment, each step of the disclosed method The average is carried out at a temperature between about 20-35 ° C, a relative humidity of about 50-100%, and aeration of about 5-200 LPM (liters per minute).
依據一較佳實施方式,所述步驟(a)、(b)及(c) 均是在黑暗中且振盪或攪拌速度介於約50-200rpm下實施:且所述步驟(d)之照度為720lux。 According to a preferred embodiment, said steps (a), (b) and (c) Both were carried out in the dark with shaking or stirring at a speed of between about 50 and 200 rpm: and the illumination of step (d) was 720 lux.
適合用於本發明的液態培養基至少包含葡萄 糖、蔗糖、蛋白腖、酵母抽出物和鹽類。非必要的,此液態培養基還可更包含黃豆粉。 Liquid medium suitable for use in the present invention comprises at least grapes Sugar, sucrose, peptone, yeast extracts and salts. Optionally, the liquid medium may further comprise soy flour.
依據一較佳實施方式,本發明方法更包含以 下步驟:(e)從步驟(d)之液態培育物中收獲靈芝菌絲體;和(f)將步驟(e)所收穫的靈芝菌絲體乾燥直到其水分含量低於5%為止,其中每公克該乾燥的靈芝菌絲體中含有約28-33毫克的三萜化合物。 According to a preferred embodiment, the method of the present invention further comprises The following steps: (e) harvesting the ganoderma mycelium from the liquid culture of the step (d); and (f) drying the ganoderma mycelium harvested in the step (e) until the moisture content thereof is less than 5%, wherein The dried Ganoderma lucidum mycelium contains about 28-33 mg of the triterpene compound per gram.
依據本發明培育方法所獲得的乾燥的靈芝菌 絲體中的三萜化合物至少包含靈芝酸S(ganoderic acid S,GAS)、靈芝酸T(ganoderic acid T,GAT)、靈芝酸Me(ganoderic acid Me,GAMe)、靈芝酸R(ganoderic acid R,GAR)、及赤靈酸S(ganodermic acid S,GMAS)。 Dried Ganoderma lucidum obtained according to the cultivation method of the present invention The triterpene compound in the filament includes at least ganoderic acid S (GAS), ganoderic acid T (GAT), ganoderic acid Me (GAMe), and ganoderic acid R (ganoderic acid R, GAR), and ganodermic acid S (GMAS).
依據一較佳實施方式,步驟(d)中的培養盤數 目為288;且依據本發明方法每隔30天可收獲至少約15公斤的乾燥靈芝菌絲體。 According to a preferred embodiment, the number of culture disks in step (d) The target is 288; and at least about 15 kg of dried Ganoderma lucidum mycelium can be harvested every 30 days in accordance with the method of the present invention.
透過以下的詳細說明、圖示與附隨之申請專 利範圍,將可更了解本揭示內容的這些及其他特徵。需知以上的概述及以下的詳細說明僅為例示,用來闡述本揭示內容,而非用以限制本揭示內容之範疇。 Through the following detailed instructions, illustrations and accompanying application These and other features of the present disclosure will be more fully appreciated. The above summary and the following detailed description are merely illustrative, and are not intended to limit the scope of the disclosure.
100‧‧‧培養系統 100‧‧‧Cultivation system
110‧‧‧外殼 110‧‧‧Shell
120、130‧‧‧培養架 120, 130‧‧‧Cultivators
120a、120b‧‧‧欄 120a, 120b‧‧‧ column
121、121a、121b‧‧‧培養盤 121, 121a, 121b‧‧‧ plates
為讓本發明的上述與其他目的、特徵、優點與實施例能更明顯易懂,所附圖式之說明如下:第1圖是依據本發明一實施方式所繪示的培養系統100的示意圖;及第2圖是依據本發明另一實施方式所繪示的培養盤121a和培養架120的示意圖。 The above and other objects, features, advantages and embodiments of the present invention will become more apparent and understood. 2 is a schematic view of a culture tray 121a and a culture rack 120 according to another embodiment of the present invention.
為了使本揭示內容的敘述更加詳盡與完備,下文針對了本發明的實施態樣與具體實施例提出了說明性的描述;但這並非實施或運用本發明具體實施例的唯一形式。實施方式中涵蓋了多個具體實施例的特徵以及用以建構與操作這些具體實施例的方法步驟與其順序。然而,亦可利用其他具體實施例來達成相同或均等的功能與步驟順序。 The description of the embodiments of the present invention is intended to be illustrative and not restrictive. The features of various specific embodiments, as well as the method steps and sequences thereof, are constructed and manipulated in the embodiments. However, other specific embodiments may be utilized to achieve the same or equivalent function and sequence of steps.
雖然用以界定本發明較廣範圍的數值範圍與參數皆是約略的數值,此處已盡可能精確地呈現具體實施例中的相關數值。然而,任何數值本質上不可避免地含有因個別測試方法所致的標準偏差。在此處,「約」通常係指實際數值在一特定數值或範圍的正負10%、5%、 1%或0.5%之內。或者是,「約」一詞代表實際數值落在平均值的可接受標準誤差之內,視本發明所屬技術領域中具有通常知識者的考量而定。除了實驗例之外,或除非另有明確的說明,當可理解此處所用的所有範圍、數量、數值與百分比(例如用以描述材料用量、時間長短、溫度、操作條件、數量比例及其他相似者)均經過「約」的修飾。因此,除非另有相反的說明,本說明書與附隨 申請專利範圍所揭示的數值參數皆為約略的數值,且可 視需求而更動。至少應將這些數值參數理解為所指出的有效位數與套用一般進位法所得到的數值。 Although numerical ranges and parameters are used to define a broad range of values for the present invention, the relevant values in the specific embodiments have been presented as precisely as possible. However, any numerical value inherently inevitably contains standard deviations due to individual test methods. Here, "about" usually means the actual value is plus or minus 10%, 5% of a specific value or range, Within 1% or 0.5%. Alternatively, the term "about" means that the actual value falls within the acceptable standard error of the average, depending on the considerations of those of ordinary skill in the art to which the invention pertains. Except for the experimental examples, or unless otherwise explicitly stated, all ranges, quantities, values, and percentages used herein are understood (eg, to describe the amount of material used, the length of time, the temperature, the operating conditions, the quantity ratio, and the like. Are all modified by "about". Therefore, unless otherwise stated to the contrary, this specification and accompanying The numerical parameters disclosed in the scope of the patent application are approximate values and can be Change according to demand. At a minimum, these numerical parameters should be understood as the number of significant digits indicated and the values obtained by applying the general carry method.
除非本說明書另有定義,此處所用的科學與技術詞彙之含義與本發明所屬技術領域中具有通常知識者所理解與慣用的意義相同。此外,在不和上下文衝突的情形下,本說明書所用的單數名詞涵蓋該名詞的複數型;而所用的複數名詞時亦涵蓋該名詞的單數型。 The scientific and technical terms used herein have the same meaning as commonly understood by those of ordinary skill in the art to which the invention pertains, unless otherwise defined herein. In addition, the singular noun used in this specification covers the plural of the noun in the case of no conflict with the context; the plural noun of the noun is also included in the plural noun used.
本揭示內容係關於一種工業級培養靈芝菌絲體的方法,依據所揭示方法,每隔30天可收獲至少約15公斤的乾燥靈芝菌絲體,其中每公克乾燥靈芝菌絲體含高達約28-33毫克的三萜化合物,其至少包含靈芝酸S(ganoderic acid S,GAS)、靈芝酸T(ganoderic acid T,GAT)、靈芝酸Me(ganoderic acid Me,GAMe)、靈芝酸R(ganoderic acid R,GAR)和赤靈酸S(ganodermic acid S,GMAS)。此外,依據本揭示內容,若需要將產量放大時,僅需將所揭示批次製程成比例放大(即,2倍、3倍或更多),即可獲得成比例量的乾燥靈芝菌絲體。 The present disclosure relates to a method for the industrial grade cultivation of Ganoderma lucidum mycelium, according to the disclosed method, at least about 15 kg of dried Ganoderma lucidum mycelium can be harvested every 30 days, wherein each g of dried Ganoderma lucidum mycelium contains up to about 28 -33 mg of a triterpene compound containing at least ganoderic acid S (GAS), ganoderic acid T (GAT), ganoderic acid Me (GAMe), and ganoderic acid R (ganoderic acid) R, GAR) and ganodermic acid S (GMAS). In addition, according to the present disclosure, if it is necessary to enlarge the yield, it is only necessary to scale up the disclosed batch process (ie, 2 times, 3 times or more) to obtain a proportional amount of dried Ganoderma lucidum mycelium. .
依據所揭示培育靈芝菌絲體的方法,其至少包含四個階段。在第一階段,先將靈芝菌絲體接種在內含不超過1公升第一液態培養基的培養瓶內,並於適當培養條件下培育約5-15天。較佳是,將靈芝菌絲體接種不超過0.8公升,更佳是不超過0.5公升的第一液態培養基內。所揭示的第一液態培養基至少包含:1.5%葡萄糖、1.5%蔗糖、0.5%蛋白腖、0.2%酵母抽出物、和0.06%KH2PO4。 接種後,於持續振盪的情況下,將整個液態培養基培養在符合以下條件的環境下:振盪速度介於約50-120rpm,例如約50、55、60、65、70、75、80、85、90、95、100、105、110、115或120rpm;溫度介於約20-35℃,例如約20、21、22、23、24、25、26、27、28、29、30、31、32、33、34或35℃;培育約5-15天,例如約5、6、7、8、9、10、11、12、13、14或15天。較佳是,振盪速度是介於約65-105rpm,例如約65、70、75、80、85、90、95、100或105rpm;溫度介於約22-33℃,例如約22、23、24、25、26、27、28、29、30、31、32或33℃;培育約8-12天,例如約8、9、10、11或12天;更佳是,振盪速度是介於約75-90rpm,例如約75、80、85或90、rpm;溫度介於約25-30℃,例如約25、26、27、28、29或30℃;培育約9-11天,例如約9、10或11天。在一較佳實施方式中,係在振盪速度約85rpm、溫度約28℃下培育約10天。 According to the disclosed method of cultivating the mycelium of Ganoderma lucidum, it comprises at least four stages. In the first stage, the Ganoderma lucidum mycelium is first inoculated into a culture flask containing not more than 1 liter of the first liquid medium, and cultured under appropriate culture conditions for about 5-15 days. Preferably, the ganoderma mycelium is inoculated to a first liquid medium of no more than 0.8 liters, more preferably no more than 0.5 liters. The disclosed first liquid medium comprises at least: 1.5% glucose, 1.5% sucrose, 0.5% peptone, 0.2% yeast extract, and 0.06% KH 2 PO 4 . After inoculation, the entire liquid medium is cultured under an environment of continuous shaking: an oscillation speed of about 50-120 rpm, for example about 50, 55, 60, 65, 70, 75, 80, 85, 90, 95, 100, 105, 110, 115 or 120 rpm; temperature between about 20-35 ° C, for example about 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32 33, 34 or 35 ° C; for about 5-15 days, for example about 5, 6, 7, 8, 9, 10, 11, 12, 13, 14 or 15 days. Preferably, the oscillation speed is between about 65-105 rpm, such as about 65, 70, 75, 80, 85, 90, 95, 100 or 105 rpm; the temperature is between about 22-33 ° C, for example about 22, 23, 24 25, 26, 27, 28, 29, 30, 31, 32 or 33 ° C; for about 8-12 days, for example about 8, 9, 10, 11 or 12 days; more preferably, the oscillation speed is between about 75-90 rpm, such as about 75, 80, 85 or 90, rpm; temperature between about 25-30 ° C, such as about 25, 26, 27, 28, 29 or 30 ° C; incubation about 9-11 days, for example about 9 , 10 or 11 days. In a preferred embodiment, the incubation is carried out for about 10 days at an oscillation speed of about 85 rpm and a temperature of about 28 °C.
在第二階段,先將第一階段所收穫的液態培育物接種在內含至少30公升第一液態培養基的醱酵槽內, 並於適當培養條件下培育約2-5天。類似的,接種後,於持續攪拌的情況下,將整個液態培養基培養在符合以下條件的環境下:攪拌速度介於約80-200rpm,例如約80、85、90、95、100、105、110、115、120、125、130、135、140、145、150、155、160、165、170、175、180、185、190、195或200rpm;通氣量介於約5-15LPM,例如約5、6、7、8、9、10、11、12、13、14或15LPM;和溫度介於約20-35℃,例如約20、21、22、23、24、25、26、27、28、29、30、31、32、33、34或35℃;培育約1-5天,例如約1、2、3、4或5天。較佳是,攪拌速度是介於約110-170rpm,例如約110、115、120、125、130、135、140、145、150、155、160、165或170rpm;通氣量介於約7-12LPM,例如約7、8、9、10、11或12LPM;溫度介於約22-33℃,例如約22、23、24、25、26、27、28、29、30、31、32或33℃;培育約2-4天,例如約2、3或4天;更佳是,攪拌速度是介於約120-160rpm,例如約120、125、130、135、140、145、150、155或160rpm;通氣量介於約9-10LPM,例如約9或10LPM;;溫度介於約25-30℃,例如約25、26、27、28、29或30℃;培育約3天。在一較佳實施方式中,係在攪拌速度約150rpm、通氣量約10LPM、溫度約28℃下培育約3天。 In the second stage, the liquid culture harvested in the first stage is first inoculated into a fermentation tank containing at least 30 liters of the first liquid medium. And incubated for about 2-5 days under appropriate culture conditions. Similarly, after inoculation, the entire liquid medium is cultured under constant agitation in an environment that satisfies the following conditions: agitation speed is between about 80 and 200 rpm, for example, about 80, 85, 90, 95, 100, 105, 110. , 115, 120, 125, 130, 135, 140, 145, 150, 155, 160, 165, 170, 175, 180, 185, 190, 195 or 200 rpm; the amount of ventilation is between about 5-15 LPM, for example about 5, 6, 7, 8, 9, 10, 11, 12, 13, 14 or 15 LPM; and a temperature between about 20-35 ° C, such as about 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34 or 35 ° C; incubation for about 1-5 days, for example about 1, 2, 3, 4 or 5 days. Preferably, the agitation speed is between about 110 and 170 rpm, such as about 110, 115, 120, 125, 130, 135, 140, 145, 150, 155, 160, 165 or 170 rpm; the aeration is between about 7 and 12 LPM. , for example, about 7, 8, 9, 10, 11 or 12 LPM; temperature is between about 22 and 33 ° C, for example about 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32 or 33 ° C Incubating for about 2-4 days, for example about 2, 3 or 4 days; more preferably, the stirring speed is between about 120-160 rpm, for example about 120, 125, 130, 135, 140, 145, 150, 155 or 160 rpm. The aeration is between about 9-10 LPM, such as about 9 or 10 LPM; the temperature is between about 25-30 °C, such as about 25, 26, 27, 28, 29 or 30 °C; incubation is about 3 days. In a preferred embodiment, the incubation is carried out for about 3 days at a stirring speed of about 150 rpm, an aeration of about 10 LPM, and a temperature of about 28 °C.
在第三階段,先將第二階段所收穫的液態培育物接種在內含至少300公升第二液態培養基的醱酵桶內,並於適當培養條件下培育約2-6天。第二液態培養基 至少包含:3%葡萄糖、6.5%蔗糖、1.0%蛋白腖、3%黃豆粉、0.6%酵母抽出物、0.06%KH2PO4和0.05%MgSO4。類似的,接種後,於持續攪拌的情況下,將整個液態培養基培養在符合以下條件的環境下:攪拌速度介於約50-150rpm,例如約50、55、60、65、70、75、80、85、90、95、100、105、110、115、120、125、130、135、140、145或150rpm;通氣量介於約50-150LPM,例如約50、60、70、80、90、100、110、120、130、140或150LPM;和溫度介於約20-35℃,例如約20、21、22、23、24、25、26、27、28、29、30、31、32、33、34或35℃;培育約2-6天,例如約2、3、4、5或6天。較佳是,攪拌速度是介於約70-130rpm,例如約70、75、80、85、90、95、100、105、110、115、120、125或130rpm;通氣量介於約80-130LPM,例如約80、90、100、110、120或130LPM;溫度介於約22-33℃,例如約22、23、24、25、26、27、28、29、30、31、32或33℃;培育約3-5天,例如約3、4或5天;更佳是,攪拌速度是介於約85-115rpm,例如約85、90、95、100、105、110或115rpm;通氣量介於約90-110LPM,例如約90、100或110LPM;溫度介於約25-30℃,例如約25、26、27、28、29或30℃;培育約4天。在一較佳實施方式中,係在攪拌速度約110rpm、通氣量約100LPM、溫度約28℃下培育約4天。 In the third stage, the liquid culture harvested in the second stage is first inoculated into a fermenter containing at least 300 liters of the second liquid medium and incubated under appropriate culture conditions for about 2-6 days. The second liquid medium comprises at least: 3% glucose, 6.5% sucrose, 1.0% peptone, 3% soy flour, 0.6% yeast extract, 0.06% KH 2 PO 4 and 0.05% MgSO 4 . Similarly, after inoculation, the entire liquid medium is cultured under constant agitation in an environment that satisfies the following conditions: agitation speed is between about 50-150 rpm, for example about 50, 55, 60, 65, 70, 75, 80. 85, 90, 95, 100, 105, 110, 115, 120, 125, 130, 135, 140, 145 or 150 rpm; the amount of ventilation is between about 50-150 LPM, for example about 50, 60, 70, 80, 90, 100, 110, 120, 130, 140 or 150 LPM; and a temperature between about 20-35 ° C, such as about 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34 or 35 ° C; incubation for about 2-6 days, for example about 2, 3, 4, 5 or 6 days. Preferably, the agitation speed is between about 70-130 rpm, such as about 70, 75, 80, 85, 90, 95, 100, 105, 110, 115, 120, 125 or 130 rpm; the aeration is between about 80-130 LPM. , for example, about 80, 90, 100, 110, 120 or 130 LPM; temperature is between about 22 and 33 ° C, for example about 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32 or 33 ° C Incubating for about 3-5 days, for example about 3, 4 or 5 days; more preferably, the stirring speed is between about 85-115 rpm, for example about 85, 90, 95, 100, 105, 110 or 115 rpm; At about 90-110 LPM, for example about 90, 100 or 110 LPM; temperature between about 25-30 ° C, such as about 25, 26, 27, 28, 29 or 30 ° C; incubation for about 4 days. In a preferred embodiment, the incubation is carried out for about 4 days at a stirring speed of about 110 rpm, an aeration of about 100 LPM, and a temperature of about 28 °C.
在第四階段,將第三階段所收穫的液態培育物轉移到多個培養盤中,使得每個培養盤中每毫升液態 培養基具有約1.5-2.5平方公分的表面積,之後在約200-2,000照度下培養約10-20天。簡言之,係在每一培養盤中倒入約0.5-1公升的第三階段所收穫的液態培育物,每一培養盤之面積介於約1,000-2,500平方公分間,較佳是介於約1,500-2,000平方公分間,更佳是約1,800平方公分。在本階段中,使用高達約288個培養盤來盛裝第三階段所收穫的液態培育物,以進行後續的培育。 接著,將這些盛裝有第三階段所收穫的液態培育物的培養盤堆疊起來,放在培養盤架上,推入具有溫度、濕度、通氣以及光照控制的環境中,繼續培育。詳言之,是將培育溫度控制在約20-35℃間,例如約20、21、22、23、24、25、26、27、28、29、30、31、32、33、34或35℃;相對濕度控制在約50-100%間,例如約50、60、70、80、90或100%;通氣量介於約5-20LPM間,例如約5、6、7、8、9、10、11、12、13、14、15、16、17、18、19或20LPM;光照強度約100至1,000照度間,例如約100、130、200、260、300、390、400、460、520、650、780、910或1000照度;培育約10-20天,例如約10、11、12、13、14、15、16、17、18、19或20天。較佳是將培育物維持在溫度約22-33℃間,例如約22、23、24、25、26、27、28、29、30、31、32或33℃;相對濕度控制在約70-100%間,例如約70、80、90或100%;通氣量介於約8-18LPM間,例如約8、9、10、11、12、13、14、15、16、17或18LPM;光照強度約200至780照度間,例如約200、260、300、390、400、460、520、650或780照度;培育約12-18天,例如約12、13、14、15、16、17或18天。更佳是 將培育物維持在溫度約25-30℃間,例如約25、26、27、28、29或30℃;相對濕度控制在約80-100%間,例如約80、90或100%;通氣量介於約10-16LPM間,例如約10、11、12、13、14、15或16LPM;光照強度約300至520照度間,例如約300、390、400、460或520照度;培育約14-16天,例如約14、15或16天。在一較佳實施方式中,係在通氣量約15LPM、相對溼度100%、光照強度約460照度且溫度約28℃下培育約14天。 In the fourth stage, the liquid culture harvested in the third stage is transferred to a plurality of culture trays, so that each milliliter of liquid in each culture tray The medium has a surface area of about 1.5-2.5 square centimeters and is then incubated at about 200-2,000 illuminance for about 10-20 days. In short, the liquid culture harvested in the third stage of about 0.5-1 liters is poured into each culture tray, and the area of each culture tray is between about 1,000-2,500 square centimeters, preferably between It is about 1,500-2,000 square centimeters, and more preferably about 1,800 square centimeters. In this stage, up to about 288 plates are used to hold the liquid culture harvested in the third stage for subsequent cultivation. Next, these culture trays containing the liquid culture harvested in the third stage are stacked, placed on a culture tray, pushed into an environment with temperature, humidity, ventilation, and light control to continue cultivation. In particular, the incubation temperature is controlled between about 20-35 ° C, such as about 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34 or 35. °C; relative humidity is controlled between about 50-100%, such as about 50, 60, 70, 80, 90 or 100%; the amount of ventilation is between about 5-20 LPM, for example about 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19 or 20 LPM; light intensity between about 100 and 1,000 illuminance, for example about 100, 130, 200, 260, 300, 390, 400, 460, 520 , 650, 780, 910 or 1000 illuminance; incubation for about 10-20 days, for example about 10, 11, 12, 13, 14, 15, 16, 17, 18, 19 or 20 days. Preferably, the culture is maintained at a temperature of between about 22 and 33 ° C, such as about 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32 or 33 ° C; the relative humidity is controlled at about 70- 100%, for example about 70, 80, 90 or 100%; ventilation between about 8-18 LPM, such as about 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, or 18 LPM; Intensity between about 200 and 780 illuminance, such as about 200, 260, 300, 390, 400, 460, 520, 650 or 780 illuminance; incubation for about 12-18 days, such as about 12, 13, 14, 15, 16, 17 or 18 days. Better yet Maintaining the culture at a temperature of between about 25 and 30 ° C, for example about 25, 26, 27, 28, 29 or 30 ° C; the relative humidity is controlled between about 80 and 100%, for example about 80, 90 or 100%; Between about 10-16 LPM, such as about 10, 11, 12, 13, 14, 15 or 16 LPM; light intensity between about 300 and 520 illuminance, such as about 300, 390, 400, 460 or 520 illuminance; incubation about 14- 16 days, for example about 14, 15 or 16 days. In a preferred embodiment, the incubation is for about 14 days at an aeration of about 15 LPM, a relative humidity of 100%, an illumination intensity of about 460 illuminance, and a temperature of about 28 °C.
典型的情況是在如第1圖所示的培育系統100中進行第四階段的培育。此培育系統100包括一外殼110以及至少4個培養架;但第1圖中僅示出兩個培養架(120,130)。每一培養架(120)分別包含兩欄(120a,120b),每一欄可分別置入至少一個培養盤(121a)。培養盤可由金屬或塑膠材料製成,且可以具有任意的形狀或大小。在如第2圖所示的實施方式中,該培養盤(121a)是由不鏽鋼金屬製成,為長方形形狀,寬度約40公分、長度約60公分且高度約5公分。每一培養架之每一欄最多可置入36個培養盤,因此每一培養架上可堆疊高達72個培養盤;故,所揭示培育系統100最多可放入288個培養盤。 Typically, the fourth stage of incubation is performed in the incubation system 100 as shown in Figure 1. This incubation system 100 includes a housing 110 and at least 4 culture racks; however, only two culture racks (120, 130) are shown in FIG. Each of the culture racks (120) respectively has two columns (120a, 120b), and each column can be respectively placed in at least one culture tray (121a). The culture tray can be made of a metal or plastic material and can have any shape or size. In the embodiment as shown in Fig. 2, the culture tray (121a) is made of stainless steel and has a rectangular shape with a width of about 40 cm, a length of about 60 cm, and a height of about 5 cm. Up to 36 plates can be placed in each column of each culture rack, so up to 72 plates can be stacked on each frame; therefore, the disclosed incubation system 100 can hold up to 288 plates.
接著,將依據以上所揭示方法而培育並收獲的靈芝菌絲體在不高於70℃的溫度下風乾,最好是在不高於60℃的溫度下風乾,直到其水分含量低於約10%以下,較佳是低於約5%以下,更佳是低於約3%以下。 Next, the Ganoderma lucidum mycelium cultivated and harvested according to the method disclosed above is air-dried at a temperature not higher than 70 ° C, preferably at a temperature not higher than 60 ° C until the moisture content thereof is less than about 10 Below %, preferably less than about 5%, more preferably less than about 3%.
一般來說,依據上述培育方法,可從每一批次培育物或300公升的第三階段液態培育物中收成約 10-20公斤的乾燥靈芝菌絲體,較佳是可收成約13-17公斤的乾燥靈芝菌絲體。 In general, according to the above cultivation method, it can be harvested from each batch of culture or 300 liters of the third stage liquid culture. The dried Ganoderma lucidum mycelium of 10-20 kg is preferably a dried Ganoderma lucidum mycelium which is about 13-17 kg.
並且,依據本發明揭示培育方法而收成的乾燥靈芝菌絲體中,每公克乾燥靈芝菌絲體中含有高達約28-33毫克的三萜化合物;較佳是,每公克乾燥靈芝菌絲體中含有高達約30毫克的三萜化合物。這些三萜化合物至少包含GAS、GAT、GAMe、GAR、及GMAS。 Moreover, in the dried Ganoderma lucidum mycelium harvested according to the present invention, up to about 28-33 mg of the triterpenoid compound per gram of dried Ganoderma lucidum mycelium; preferably, per gram of dried Ganoderma lucidum mycelium Contains up to about 30 mg of triterpenoids. These triterpenoid compounds include at least GAS, GAT, GAMe, GAR, and GMAS.
此外,當需要獲得更高量的三萜化合物時,此領域具有通常知識的相關技藝人士可輕易地藉由成倍複製此所揭示的培育方法與系統,而將所揭示製程放大,以獲得成倍(如2倍、3倍或更高倍數)的乾燥靈芝菌絲體。 In addition, when it is desired to obtain higher amounts of triterpenoids, those skilled in the art having the ordinary knowledge can readily amplify the disclosed processes and systems by multiplying the disclosed methods and systems. Drying Ganoderma lucidum mycelium at times (eg, 2 times, 3 times or higher).
以下實施例是用來闡明本揭示內容特定態樣,並幫助習知技藝者了解並實施本揭示內容。但本揭示內容範疇並不限於這些實施例中。 The following examples are presented to illustrate certain aspects of the present disclosure and to assist those skilled in the art to understand and practice the present disclosure. However, the scope of the disclosure is not limited to these embodiments.
實施例Example
實施例1 以工業級規模培育靈芝菌絲體Example 1 Incubation of Ganoderma lucidum mycelium on an industrial scale
1.1生產第一階段液態培育物1.1 Production of the first stage liquid culture
將約1平方公分的靈芝菌絲體接種在400毫升的第一液態培養基中,此第一液態培養基包含1.5%葡萄糖、1.5%蔗糖、0.5%蛋白腖、0.2%酵母抽出物、和0.06%KH2PO4。接著,以約85rpm的速度持續攪拌培育物,並在約28℃的溫度下培育約10天,所得培育物稱『第一階段液態培育物』。 About 1 square centimeter of Ganoderma lucidum mycelium was inoculated into 400 ml of a first liquid medium containing 1.5% glucose, 1.5% sucrose, 0.5% peptone, 0.2% yeast extract, and 0.06% KH 2 PO 4 . Next, the culture was continuously stirred at a rate of about 85 rpm and incubated at a temperature of about 28 ° C for about 10 days, and the resulting culture was referred to as "first stage liquid culture".
1.2生產第二階段液態培育物1.2 Production of the second stage liquid culture
將約30公升的第一液態培養基倒入體積約50公升的醱酵槽內,接著,將約2.8公升之實施例1.1的第一階段液態培育物接種在醱酵槽內的第一液態培養基中。以約150rpm的速度持續攪拌培育物,並在通氣量約10LPM、溫度約28℃下培育約3天,所得培育物稱『第二階段液態培育物』。 Approximately 30 liters of the first liquid medium was poured into a fermentation tank having a volume of about 50 liters, and then about 2.8 liters of the first stage liquid culture of Example 1.1 was inoculated into the first liquid medium in the fermentation tank. . The culture was continuously stirred at a speed of about 150 rpm and incubated for about 3 days at aeration of about 10 LPM at a temperature of about 28 ° C. The resulting culture was referred to as "second stage liquid culture".
1.3生產第三階段液態培育物1.3 Production of the third stage liquid culture
將約300公升的第二液態培養基倒入體積約500公升的醱酵槽內,接著,將約50公升之實施例1.2的第二階段液態培育物接種在醱酵槽內的第二液態培養基中。此第二液態培養基至少包含:3%葡萄糖、6.5%蔗糖、1.0%蛋白腖、3%黃豆粉、0.6%酵母抽出物、0.06%KH2PO4和0.05%MgSO4。接著,以約100rpm的速度持續攪拌培育物,並在通氣量約100LPM、溫度約28℃下培育約4天,所得培育物稱『第三階段液態培育物』。 About 300 liters of the second liquid medium was poured into a fermentation tank having a volume of about 500 liters, and then about 50 liters of the second stage liquid culture of Example 1.2 was inoculated into the second liquid medium in the fermentation tank. . The second liquid medium comprises at least: 3% glucose, 6.5% sucrose, 1.0% peptone, 3% soy flour, 0.6% yeast extract, 0.06% KH 2 PO 4 and 0.05% MgSO 4 . Next, the culture was continuously stirred at a rate of about 100 rpm, and incubated at about 100 LPM and a temperature of about 28 ° C for about 4 days, and the resulting culture was called "third stage liquid culture".
1.4放大培育第三階段液態培育物1.4 Amplification and cultivation of the third stage liquid culture
在無菌情況下,於288個培養盤(40公分x 60公分x 5公分)中分別倒入約1公升之第三階段液態培育物,接著,將培養盤放入如第1圖所示的培養系統中,於100%相對溼度、通氣量約15LPM、溫度約28℃、光照約460照度下培育約14天。收集所產生的靈芝菌絲體,並以約60℃的溫度風乾直到其含水量低於約5%為止。 In a sterile condition, pour about 1 liter of the third stage liquid culture into 288 plates (40 cm x 60 cm x 5 cm), and then place the plate into the culture as shown in Figure 1. The system was incubated for about 14 days at 100% relative humidity, aeration of about 15 LPM, temperature of about 28 ° C, and illumination of about 460 illuminance. The resulting mycelium of Ganoderma lucidum was collected and air dried at a temperature of about 60 ° C until its water content was less than about 5%.
實施例2 各培育條件對實施例1之乾燥靈芝菌絲體內三萜化合物量的影響Example 2 Effect of each incubation condition on the amount of triterpenoids in the dried Ganoderma lucidum mycelium of Example 1.
在本實施例中,透過改變實施例1.4的培育條 件以及產物中所含三萜化合物的量,來找出最適宜放大實施例1.3之第三階段液態培育物的培育條件。所測試並加以變化的培育條件包括:光照強度從0至720照度,通氣量從0至30LPM,相對溼度從50%至100%,溫度從約23℃至33℃。之後,收集各條件下所培育出來的靈芝菌絲體,於60℃的溫度下風乾直到水分含量低於5%,並測定其所含的三萜化合物(其至少包含GAS、GAT、GAMe、GAR、及GMAS)的總量。結果示於表1-5。 In this embodiment, by changing the incubation strip of embodiment 1.4 The amount of the triterpenoid compound contained in the product and the product was used to find the optimum conditions for amplifying the third stage liquid culture of Example 1.3. The incubation conditions tested and varied include: illumination intensity from 0 to 720 illuminance, ventilation from 0 to 30 LPM, relative humidity from 50% to 100%, and temperature from about 23 °C to 33 °C. Thereafter, the mycelium of Ganoderma lucidum cultivated under each condition was collected, air-dried at a temperature of 60 ° C until the moisture content was less than 5%, and the triterpenoid compound contained therein (which contained at least GAS, GAT, GAMe, GAR) was measured. And the total amount of GMAS). The results are shown in Tables 1-5.
綜合以上表1-5的結果,可發現如果將最後放大階段的靈芝培育物培育在有光照的環境下,可提高靈芝菌絲體內三萜化合物的含量高達3倍,比較表1中無光照以及光照260照度的結果,每克菌絲乾重內三萜化合物的含量從9.11毫克提高至26.66毫克。至於其他培育條件對三萜化合物含量的影響,則發現通氣量至少需達15LPM、相對溼度至少需達80%、且溫度至少需為28℃。 Based on the results in Table 1-5 above, it can be found that if the Ganoderma lucidum culture in the final amplification stage is cultivated in a light environment, the content of triterpenoids in the mycelium of Ganoderma lucidum can be increased by up to 3 times, and the light in Table 1 is compared. As a result of illumination of 260 illuminance, the content of triterpenoids per gram of dry weight of mycelium increased from 9.11 mg to 26.66 mg. As for the effect of other incubation conditions on the content of triterpenoids, it was found that the ventilation should be at least 15 LPM, the relative humidity should be at least 80%, and the temperature should be at least 28 °C.
至於系統中培養細胞的盤數,實驗也發現當培養盤數少的時候,靈芝菌絲體內三萜化合物的含量反而呈現微幅下降。推測此係因為培育系統中因培育物減少造成相對濕度下降(即,無法維持80%)所致。 As for the number of cells cultured in the system, the experiment also found that when the number of cultured disks was small, the content of triterpenoids in the mycelium of Ganoderma lucidum decreased slightly. It is speculated that this is due to a decrease in relative humidity (ie, 80% cannot be maintained) due to a decrease in the culture in the cultivation system.
當可理解上述實施方式與實施例僅為例示,且熟習此技藝者可對劑進行各種修飾。上文提出之說明書、實施例與資料的目的在於使本說明書的結構完備,並作為實作本發明之例示。雖然本揭示內容已以實施方式揭露如上,然其並非用以限定本揭示內容,任何熟習此技藝者,在不脫離本揭示內容之精神和範圍內,當可作各種之更動與潤飾,因此本揭示內容之保護範圍當視後附之申請專利範圍所界定者為準。 It will be understood that the above-described embodiments and examples are merely illustrative, and that various modifications may be made to the agent by those skilled in the art. The description, examples, and materials set forth above are intended to be illustrative of the present invention and are illustrative of the invention. The present disclosure has been disclosed in the above embodiments, but it is not intended to limit the disclosure, and any person skilled in the art can make various changes and refinements without departing from the spirit and scope of the disclosure. The scope of protection of the disclosure is subject to the definition of the scope of the patent application.
100‧‧‧培育系統 100‧‧‧Cultivation system
110‧‧‧外殼 110‧‧‧Shell
120、130‧‧‧培養架 120, 130‧‧‧Cultivators
120a、120b‧‧‧欄 120a, 120b‧‧‧ column
121a‧‧‧培養盤 121a‧‧‧culture plate
Claims (9)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TW102128574A TWI595089B (en) | 2013-08-09 | 2013-08-09 | Industrial scale process of cultivating ganoderma lucidum mycelium |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TW102128574A TWI595089B (en) | 2013-08-09 | 2013-08-09 | Industrial scale process of cultivating ganoderma lucidum mycelium |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| TW201506157A TW201506157A (en) | 2015-02-16 |
| TWI595089B true TWI595089B (en) | 2017-08-11 |
Family
ID=53019254
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW102128574A TWI595089B (en) | 2013-08-09 | 2013-08-09 | Industrial scale process of cultivating ganoderma lucidum mycelium |
Country Status (1)
| Country | Link |
|---|---|
| TW (1) | TWI595089B (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105724050A (en) * | 2016-02-17 | 2016-07-06 | 王立丽 | Cultivating method for ornamental lucid ganoderma |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1375557A (en) * | 2002-03-29 | 2002-10-23 | 华东理工大学 | Two-stage glossy ganoderma cell culturing process of producing ganoderic acid in bioreactor |
| CN101492645A (en) * | 2008-01-21 | 2009-07-29 | 湖北工业大学 | Glossy ganoderma cell culture method for accelerating biosynthesis of ganoderic acid and ganoderma iucidum polysaccharide |
| CN102870595A (en) * | 2012-09-13 | 2013-01-16 | 广东省微生物研究所 | Artificial cultivation method capable of realizing highland cultivation of wild ganoderma tsugae murr |
-
2013
- 2013-08-09 TW TW102128574A patent/TWI595089B/en active
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1375557A (en) * | 2002-03-29 | 2002-10-23 | 华东理工大学 | Two-stage glossy ganoderma cell culturing process of producing ganoderic acid in bioreactor |
| CN101492645A (en) * | 2008-01-21 | 2009-07-29 | 湖北工业大学 | Glossy ganoderma cell culture method for accelerating biosynthesis of ganoderic acid and ganoderma iucidum polysaccharide |
| CN102870595A (en) * | 2012-09-13 | 2013-01-16 | 广东省微生物研究所 | Artificial cultivation method capable of realizing highland cultivation of wild ganoderma tsugae murr |
Also Published As
| Publication number | Publication date |
|---|---|
| TW201506157A (en) | 2015-02-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US8524486B2 (en) | Culture method of Aantrodia camphorata | |
| CN105378056B (en) | Industrial-grade culture method of ganoderma lucidum mycelia | |
| CN101717710B (en) | Tibetan-flavor liquor and brewing process thereof | |
| CN103460981B (en) | A kind of Cordceps militaris novel method for cultivating | |
| JP2015037396A (en) | Culturing method of antrodia cinnamomea | |
| CN102342218A (en) | Method for producing cordyceps sinensis hyphae by virtue of solid-state fermentation | |
| KR20160147148A (en) | Cultivation method of cordyceps militaris seed mushroom | |
| US20110300606A1 (en) | Formula of medium for culturing cordyceps spp. | |
| TWI595088B (en) | A medium for mycelia of antrodia cinnamomea | |
| CN109006175B (en) | Liquid culture method for rapidly culturing cordyceps militaris stroma | |
| TWI595089B (en) | Industrial scale process of cultivating ganoderma lucidum mycelium | |
| CN103416222B (en) | Lepista nuda spore cultivation and ripening method through hypha shake flasks and liquid submerged fermentation process | |
| CN102523922A (en) | Method for cultivating Poria cocos fruiting bodies | |
| CN105838621B (en) | A kind of culture solution and breeding method of grifola frondosus liquid spawn | |
| CN117683645B (en) | Ganoderma lucidum strain L4914 and cultivation method and application thereof | |
| CN107739224A (en) | It is a kind of quickly to breed fluid nutrient medium of saussurea involucrata mushroom strains and preparation method thereof | |
| CN106883010A (en) | Antrodia growth promoter and the method with its quick fermentation production antrodia | |
| CN108901587A (en) | A kind of solid culture method of cicada fungus | |
| JPH04304890A (en) | Production of ganoderic acids | |
| TW201737793A (en) | Method for aseptically culturing fruiting bodies of antrodia cinnamomea | |
| CN103667062A (en) | Protective agent for low-temperature preservation of asexual spores of antrodia cinnamomea and protective agent using method | |
| CN110387333A (en) | A method for cultivating Antrodia camphorata with Lanping Cordyceps fungus powder | |
| CN105777360B (en) | A kind of culture solution and breeding method of grifola frondosus liquid spawn | |
| HK1219112B (en) | Industrial scale process of cultivating ganoderma lucidum mycelium | |
| CN107360852B (en) | Antrodia Cultivation Method |